Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eltrombopag in MYH9-related disease
NCT01133860Phase 2Completed
- Sponsor
- IRCCS San Matteo Foundation
- Start
- Jan 2009
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of eltrombopag in MYH9-related disorder (MYH9-RD), sponsored by IRCCS San Matteo Foundation. Primary endpoint: Response to Drug Based on Platelet Count at 72 days. Started Jan 2009; status: completed.
02
Drugs
eltrombopag
03
Conditions
MYH9-related disorder (MYH9-RD)
Beyond the preview
Go deeper on NCT01133860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01133860.